Literature DB >> 2704733

An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes.

D Y Tuan1, W B Solomon, I M London, D P Lee.   

Abstract

We have identified an erythroid-specific enhancer element far upstream of the human "beta-like globin" genes, at 10.2-11.0 kilobases 5' of the embryonic epsilon-globin gene, and thus at 53-54 kilobases 5' of the adult beta-globin gene. It is capable of enhancing the expression of a cis-linked test gene by up to 300-fold. This enhancer element is apparently developmental-stage-independent, as it is functional at the embryonic and the adult developmental stages in erythroid cells that are expressing the respective beta-like globin genes. The enhancer and globin promoter sequences work in synergy and are capable of conferring on a cis-linked gene the high transcriptional efficiency (enhancer function), erythroid specificity (enhancer and promoter functions), and developmental-stage specificity (promoter function) that are characteristic of the in vivo transcription of the beta-like globin genes in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704733      PMCID: PMC286955          DOI: 10.1073/pnas.86.8.2554

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Bidirectional control of the chicken beta- and epsilon-globin genes by a shared enhancer.

Authors:  J M Nickol; G Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 2.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Unexpected relationships between four large deletions in the human beta-globin gene cluster.

Authors:  E F Vanin; P S Henthorn; D Kioussis; F Grosveld; O Smithies
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

Authors:  J Banerji; S Rusconi; W Schaffner
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

5.  The primary structure of the human epsilon-globin gene.

Authors:  F E Baralle; C C Shoulders; N J Proudfoot
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

6.  Embryonic-fetal erythroid characteristics of a human leukemic cell line.

Authors:  E J Benz; M J Murnane; B L Tonkonow; B W Berman; E M Mazur; C Cavallesco; T Jenko; E L Snyder; B G Forget; R Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  gamma-beta-Thalassaemia studies showing that deletion of the gamma- and delta-genes influences beta-globin gene expression in man.

Authors:  L H Van der Ploeg; A Konings; M Oort; D Roos; L Bernini; R A Flavell
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

9.  Beta-globin gene inactivation by DNA translocation in gamma beta-thalassaemia.

Authors:  D Kioussis; E Vanin; T deLange; R A Flavell; F G Grosveld
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

10.  Interleukin 1 production by a human acute monocytic leukemia cell line.

Authors:  T Krakauer; J J Oppenheim
Journal:  Cell Immunol       Date:  1983-09       Impact factor: 4.868

View more
  114 in total

1.  Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.

Authors:  J C McDowell; A Dean
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  The role of trans-acting factors and DNA-bending in the silencing of human beta-globin gene expression.

Authors:  L R Drew; D C Tang; P E Berg; G P Rodgers
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells.

Authors:  Jianhua Ling; Wenhu Pi; Roni Bollag; Shan Zeng; Meral Keskintepe; Hatem Saliman; Sanford Krantz; Barry Whitney; Dorothy Tuan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.

Authors:  M A McDevitt; Y Fujiwara; R A Shivdasani; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

6.  The ERV-9 LTR enhancer is not blocked by the HS5 insulator and synthesizes through the HS5 site non-coding, long RNAs that regulate LTR enhancer function.

Authors:  Jianhua Ling; Wenhu Pi; Xiuping Yu; Chikh Bengra; Qiaoming Long; Huaqian Jin; Andreas Seyfang; Dorothy Tuan
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

7.  Transcription of the hypersensitive site HS2 enhancer in erythroid cells.

Authors:  D Tuan; S Kong; K Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Structure and function of the enhancer 3' to the human A gamma globin gene.

Authors:  M Purucker; D Bodine; H Lin; K McDonagh; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

9.  Homologous recombination in hybridoma cells: dependence on time and fragment length.

Authors:  M J Shulman; L Nissen; C Collins
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

10.  Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease.

Authors:  K J Takekoshi; Y H Oh; K W Westerman; I M London; P Leboulch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.